Litcius/Paper detail

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial

Lameck Chinula, Lauren Ziemba, Sean S. Brummel, Katie McCarthy, Anne Coletti, Chelsea Krotje, Benjamin Johnston, Kevin Knowles, Sikhulile Moyo, Lynda Stranix‐Chibanda, Risa M. Hoffman, Paul E. Sax, Jeffrey S. A. Stringer, Nahida Chakhtoura, Patrick Jean‐Philippe, Violet Korutaro, Haseena Cassim, Lee Fairlie, Gaerolwe Masheto, Ceejay L. Boyce, Lisa M. Frenkel, K. Rivet Amico, Lynette Purdue, Roger Shapiro, Blandina T. Mmbaga, Faeezah Patel, Jean van Wyk, James F. Rooney, Judith S. Currier, Shahin Lockman, Brookie M. Best, Cheryl Blanchette, Renee Browning, Nagawa Jaliaah, Mark Mirochnick, William Murtaugh, Emmanuel Patras, Frances Whalen, Jeremiah D. Momper, Ponego Ponatshego, Lesedi Tirelo, Boitshepo J Seme, Georginah O Modise, Mpho S. Raesi, Marian Budu, Moakanyi Ramogodiri, Ricardo Hugo de Oliveira, Cristina B Hofe, Thalita Fernandes de Abreu, Lorena Macedo Pestanha, Esaú João, Leon Claude Sidi, Trevon Fuller, Maria Letícia Santos Cruz, Jorge Pinto, Flãvia Ferreira, Mário Dias Corrêa Júnior, Juliana Ribeiro Romeiro, José Henrique Pilotto, Luis Eduardo Fernandes, Luiz F. Moreira, Ivete Martins Gomes, Shilpa Naik, Neetal Nevrekar, Vidya Mave, Aarti Kinikar, Elizea Horne, Hamisha Soma-Kasiram, Avy Violari, Sisinyana Ruth Mathiba, Mandisa Nyati, Gerhard Theron, Jeanne De Jager, Magdel Rossouw, Lindie Rossouw, Sherika Hanley, Alicia C. Desmond, Rosemary Gazu, Vani Govender, Amphan Chalermchockcharoenkit, Manopchai Thamkhantho, Peerawong Werarak, Supattra Rungmaitree, Jullapong Achalapong, Lukkana Sitiritkawin, Tim R. Cressey, Pra-ornsuda Sukrakanchana, Linda Aurpibul, Fuanglada Tongprasert, Chintana Khamrong, Sopida Kiattivej, Deo Wabwire, Enid Kabugo, Joel Maena, Frances Nakayiwa, Victoria Ndyanabangi, Beatrice Nagaddya, Rogers Sekabira, Justus Ashaba, Charles D. Mitchell

2023The Lancet HIV29 citationsDOIOpen Access PDF

Topics & Concepts

MedicineEfavirenzEmtricitabineAdverse effectPregnancyObstetricsDolutegravirTenofovir alafenamideNevirapinePediatricsInternal medicineViral loadAntiretroviral therapyHuman immunodeficiency virus (HIV)ImmunologyBiologyGeneticsHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHIV Research and Treatment
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial | Litcius